Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix

NCT: NCT02901626 · TERMINATED

NCT IDNCT02901626
StatusTERMINATED
Start Date2017-02-14
Completion2022-05-10
SponsorThe George Washington University Biostatistics Center (OTHER)
First posted
Last updated

Brief Summary

The purpose of the study is to determine whether the Arabin pessary is a useful intervention of preterm birth at less than 37 weeks in women with a singleton gestation and a short cervix.

Frequently Asked Questions

What is A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix?

A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix is a clinical trial registered under NCT02901626. Current status: TERMINATED.

What is the status of NCT02901626?

The current status of NCT02901626 (A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix) is: TERMINATED.

When did A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix start?

A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix started on 2017-02-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.